Developmental brain dysfunction: Revival and expansion of old concepts based on new genetic evidence

The Lancet Neurology

Volumn 12, Issue 4, 2013, Pages 406-414

  Moreno De Luca, Andres ^a,b   Myers, Scott M ^a,b   Challman, Thomas D ^a,b   Moreno De Luca, Daniel ^c   Evans, David W ^a,b   Ledbetter, David H ^a,b  

^a GEISINGER HEALTH SYSTEM   (United States)

^b BUCKNELL UNIVERSITY   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEHAVIOR; BRAIN DYSFUNCTION; COGNITIVE DEVELOPMENT; DEVELOPMENTAL DISORDER; GENE DELETION; GENE DOSAGE; GENE MUTATION; GENETIC TRAIT; GENETIC VARIABILITY; GENETICS; HUMAN; MOTOR DEVELOPMENT; NOTE; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; AUTISTIC DISORDER; BRAIN DISEASES; DEVELOPMENTAL DISABILITIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NERVOUS SYSTEM DISEASES;

EID: 84875237809     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(13)70011-5     Document Type: Note

References (76)

1. DSM-5 Development, 2012 American Psychiatric Association, (accessed Sept 17, 2012). http://www.dsm5.org.
2. Reiss AL Childhood developmental disorders: an academic and clinical convergence point for psychiatry, neurology, psychology and pediatrics. J Child Psychol Psychiatry 2009, 50:87-98.
3. Johnson MR, Shorvon SD Heredity in epilepsy: neurodevelopment, comorbidity, and the neurological trait. Epilepsy Behav 2011, 22:421-427.
4. Rapoport JL, Giedd JN, Gogtay N Neurodevelopmental model of schizophrenia: update 2012. Mol Psychiatry 2012, 17:1228-1238.
5. Myers SM Diagnosis of developmental disabilities. Children with disabilities 2013, 243-266. Paul H. Brookes Publishing Co, Baltimore. 7th edn. M.L. Batshaw, G.R. Lotrecchiano, N.J. Roizen (Eds.).
6. Yeargin-Allsopp M, Boyle C, van Naarden-Braun K, Trevathan E The epidemiology of developmental disabilities. Capute and Accardo's neurodevelopmental disabilities in infancy and childhood 2008, 61-104. Paul H. Brookes Publishing Co, Baltimore. P.J. Accardo (Ed.).
7. Piek JP, Pitcher TM, Hay DA Motor coordination and kinaesthesis in boys with attention deficit-hyperactivity disorder. Dev Med Child Neurol 1999, 41:159-165.
8. Taurines R, Schmitt J, Renner T, Conner AC, Warnke A, Romanos M Developmental comorbidity in attention-deficit/hyperactivity disorder. Attent Defic Hyperact Disord 2010, 2:267-289.
9. Willcutt EG, Pennington BF, Duncan L, et al. Understanding the complex etiologies of developmental disorders: behavioral and molecular genetic approaches. J Dev Behav Pediatr 2010, 31:533-544.
10. Pennington BF, Bishop DV Relations among speech, language, and reading disorders. Annu Rev Psychol 2009, 60:283-306.
11. Odding E, Roebroeck ME, Stam HJ The epidemiology of cerebral palsy: incidence, impairments and risk factors. Disabil Rehabil 2006, 28:183-191.
12. Moreno-De-Luca A, Ledbetter DH, Martin CL Genetic insights into the causes and classification of the cerebral palsies. Lancet Neurol 2012, 11:283-292.
13. Einfeld SL, Ellis LA, Emerson E Comorbidity of intellectual disability and mental disorder in children and adolescents: a systematic review. J Intellect Dev Disabil 2011, 36:137-143.
14. Mazefsky CA, Oswald DP, Day TN, et al. ASD, a psychiatric disorder, or both? Psychiatric diagnoses in adolescents with high-functioning ASD. J Clin Child Adolesc Psycho 2012, 41:516-523.
15. Denckla MB Minimal brain dysfunction. Education and the brain 1978, 223-268. University of Chicago Press, Chicago, IL. J.S. Chall, A.F. Mirsky (Eds.).
16. Strauss AS, Lehtinen MA Psychopathology and education of the brain-injured child 1947, Grune and Stratton, New York.
17. Clemmens RL Syndromes of minimal brain dysfunction in children. Md State Med J 1966, 15:139-140.
18. Zigler E Familial mental retardation: a continuing dilemma. Science 1967, 155:292-298.
19. Weisz JR, Zigler E Cognitive development in retarded and nonretarded persons: Piagetian tests of the similar sequence hypothesis. Psychol Bull 1979, 86:831-851.
20. Cicchetti D, Pogge-Hesse P Possible contributions of the study of organically retarded persons to developmental theory. Mental retardation: the developmental-difference controversy 1982, 277-318. Erlbaum, Hillsdale, NJ. E. Zigler, D. Balla (Eds.).
21. Hodapp RM, Zigler E Applying the developmental perspective to Down syndrome. Children with Down syndrome: A developmental perspective 1990, 1-28. Cambridge University Press, New York. D. Cicchetti, M. Beeghly (Eds.).
22. Capute AJ, Palmer FB A pediatric overview of the spectrum of developmental disabilities. J Dev Behav Pediatr 1980, 1:66-69.
23. Capute AJ, Accardo PJ A Neurodevelopmental perspective on the continuum of developmental disabilities. Developmental disabilities in infancy and childhood 1991, Paul H Brookes Publishing Co, Baltimore. A.J. Capute, P.J. Accardo (Eds.).
24. Gilger JW, Kaplan BJ Atypical brain development: a conceptual framework for understanding developmental learning disabilities. Dev Neuropsychol 2001, 20:465-481.
25. Gillberg C The ESSENCE in child psychiatry: early symptomatic syndromes eliciting neurodevelopmental clinical examinations. Res Dev Disabil 2010, 31:1543-1551.
26. Kaminsky EB, Kaul V, Paschall J, et al. An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities. Genet Med 2011, 13:777-784.
27. Cooper GM, Coe BP, Girirajan S, et al. A copy number variation morbidity map of developmental delay. Nat Genet 2011, 43:838-846.
28. Girirajan S, Brkanac Z, Coe BP, et al. Relative burden of large CNVs on a range of neurodevelopmental phenotypes. PLoS Genet 2011, 7:e1002334.
29. Sanders SJ, Murtha MT, Gupta AR, et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 2012, 485:237-241.
30. O'Roak BJ, Vives L, Girirajan S, et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 2012, 485:246-250.
31. Najmabadi H, Hu H, Garshasbi M, et al. Deep sequencing reveals 50 novel genes for recessive cognitive disorders. Nature 2011, 478:57-63.
32. Xu B, Roos JL, Dexheimer P, et al. Exome sequencing supports a de novo mutational paradigm for schizophrenia. Nat Genet 2011, 43:864-868.
33. Moreno-De-Luca D, Sanders S, Willsey A, et al. Using large clinical datasets to infer pathogenicity for rare copy number variants in autism cohorts. Mol Psychiatry 2012, published online Oct 9. 10.1038/mp.2012.138.
34. Bassett AS, McDonald-McGinn DM, Devriendt K, et al. Practical guidelines for managing patients with 22q11.2 deletion syndrome. J Pediatr 2011, 159:332-339.
35. Moss EM, Batshaw ML, Solot CB, et al. Psychoeducational profile of the 22q11.2 microdeletion: a complex pattern. J Pediatr 1999, 134:193-198.
36. Zufferey F, Sherr E, Beckmann N, et al. A 600 kb deletion syndrome at 16p11.2 leads to energy imbalance and neuropsychiatric disorders. J Med Genet 2012, 49:660-668.
37. Kumar RA, KaraMohamed S, Sudi J, et al. Recurrent 16p11.2 microdeletions in autism. Hum Mol Genet 2008, 17:628-638.
38. Weiss LA, Shen Y, Korn JM, et al. Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 2008, 358:667-675.
39. Shinawi M, Liu P, Kang SH, et al. Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size. J Med Genet 2010, 47:332-341.
40. Dale RC, Grattan-Smith P, Fung VS, Peters GB Infantile convulsions and paroxysmal kinesigenic dyskinesia with 16p11.2 microdeletion. Neurology 2011, 77:1401-1402.
41. Jacquemont S, Reymond A, Zufferey F, et al. Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus. Nature 2011, 478:97-102.
42. Christiansen J, Dyck JD, Elyas BG, et al. Chromosome 1q21.1 contiguous gene deletion is associated with congenital heart disease. Circ Res 2004, 94:1429-1435.
43. Stefansson H, Rujescu D, Cichon S, et al. Large recurrent microdeletions associated with schizophrenia. Nature 2008, 455:232-236.
44. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008, 455:237-241. International Schizophrenia Consortium.
45. Mefford HC, Sharp AJ, Baker C, et al. Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N Engl J Med 2008, 359:1685-1699.
46. Szatmari P, Paterson AD, Zwaigenbaum L, et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet 2007, 39:319-328.
47. Harvard C, Strong E, Mercier E, et al. Understanding the impact of 1q21.1 copy number variant. Orphanet J Rare Dis 2011, 6:54.
48. Sharp AJ, Mefford HC, Li K, et al. A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures. Nat Genet 2008, 40:322-328.
49. Pagnamenta AT, Wing K, Sadighi Akha E, et al. A 15q13.3 microdeletion segregating with autism. Eur J Hum Genet 2009, 17:687-692.
50. Ben-Shachar S, Lanpher B, German JR, et al. Microdeletion 15q13.3: a locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders. J Med Genet 2009, 46:382-388.
51. Moreno-De-Luca D, Mulle JG, Kaminsky EB, et al. Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia. Am J Hum Genet 2010, 87:618-630.
52. Nagamani SC, Erez A, Shen J, et al. Clinical spectrum associated with recurrent genomic rearrangements in chromosome 17q12. Eur J Hum Genet 2010, 18:278-284.
53. Loirat C, Bellanne-Chantelot C, Husson I, et al. Autism in three patients with cystic or hyperechogenic kidneys and chromosome 17q12 deletion. Nephrol Dial Transplant 2010, 25:3430-3433.
54. Verkerk AJ, Mathews CA, Joosse M, Eussen BH, Heutink P, Oostra BA CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder. Genomics 2003, 82:1-9.
55. Strauss KA, Puffenberger EG, Huentelman MJ, et al. Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2. N Engl J Med 2006, 354:1370-1377.
56. Friedman JI, Vrijenhoek T, Markx S, et al. CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Mol Psychiatry 2008, 13:261-266.
57. O'Roak BJ, Deriziotis P, Lee C, et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet 2011, 43:585-589.
58. Zweier C, de Jong EK, Zweier M, et al. CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in drosophila. Am J Hum Genet 2009, 85:655-666.
59. Schaaf CP, Boone PM, Sampath S, et al. Phenotypic spectrum and genotype-phenotype correlations of NRXN1 exon deletions. Eur J Hum Genet 2012, 20:1240-1247.
60. Ching MS, Shen Y, Tan WH, et al. Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders. Am J Med Genet 2010, 153:937-947.
61. Duong L, Klitten LL, Moller RS, et al. Mutations in NRXN1 in a family multiply affected with brain disorders: NRXN1 mutations and brain disorders. Am J Med Genet 2012, 159:354-358.
62. Gauthier J, Siddiqui TJ, Huashan P, et al. Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. Hum Genet 2011, 130:563-573.
63. Dibbens LM, Tarpey PS, Hynes K, et al. X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment. Nat Genet 2008, 40:776-781.
64. Depienne C, Bouteiller D, Keren B, et al. Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females. PLoS Genet 2009, 5:e1000381.
65. Camacho A, Simon R, Sanz R, Vinuela A, Martinez-Salio A, Mateos F Cognitive and behavioral profile in females with epilepsy with PDCH19 mutation: two novel mutations and review of the literature. Epilepsy Behav 2012, 24:134-137.
66. Brandon NJ, Sawa A Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nat Rev Neurosci 2011, 12:707-722.
67. Endele S, Rosenberger G, Geider K, et al. Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes. Nat Genet 2010, 42:1021-1026.
68. Constantino JN, Davis SA, Todd RD, et al. Validation of a brief quantitative measure of autistic traits: comparison of the social responsiveness scale with the autism diagnostic interview-revised. J Autism Dev Disord 2003, 33:427-433.
69. Constantino JN The quantitative nature of autistic social impairment. Pediatr Res 2011, 69:55-62.
70. Achenbach TM The Achenbach system of empirically based assessemnt (ASEBA): development, findings, theory, and applications 2009, University of Vermont Research Center for Children, Youth and Families, Burlington, VT.
71. Evans DW, Leckman JF, Carter A, et al. Ritual, habit, and perfectionism: the prevalence and development of compulsive-like behavior in normal young children. Child Dev 1997, 68:58-68.
72. Denckla MB Revised neurological examination for subtle signs (1985). Psychopharmacol Bull 1985, 21:773-800.
73. Bruininks RH, Bruininks BD Test of motor proficiency 2005, AGS Publishing, Circle Pines, MN. 2nd edn.
74. Identifying infants and young children with developmental disorders in the medical home: an algorithm for developmental surveillance and screening. Pediatrics 2006, 118:405-420. American Academy of Pediatrics.
75. Manning M, Hudgins L Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med 2010, 12:742-745.
76. Michelson DJ, Shevell MI, Sherr EH, Moeschler JB, Gropman AL, Ashwal S Evidence report: genetic and metabolic testing on children with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2011, 77:1629-1635.